Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Severe RA.
Inadequate response (or intolerant) to non-biological DMARDs or one biologic agent
Participants initiating treatment with tocilizumab on their physician's decision (in accordance with the local label), including participants who started treatment with tocilizumab within the 8 weeks prior to the enrolment visit.
You may not be if
Tocilizumab treatment more than 8 weeks prior to the enrolment visit.
Previous tocilizumab treatment in a clinical trial or for compassionate use.
Enrolled in an ongoing clinical trial and/or treatment with any investigational agent within 4 weeks (or 5 half-lives of the investigational agent, whichever is longer) before starting treatment with tocilizumab.
History of autoimmune disease or any joint inflammatory disease other than RA.
